Survival of patients with ANCA-associated vasculitis on chronic dialysis: Data from the French REIN registry from 2002 to 2011

QJM: An International Journal of Medicine

Volumn 107, Issue 7, 2014, Pages 545-555

  Romeu, M ^a   Couchoud, C ^b   Delaroziere J C ^a   Burtey, S ^a   Chiche, L ^a   Harle J R ^a   Gondouin, B ^a   Brunet, P ^a   Berland, Y ^a   Jourde Chiche, N ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b AGENCE DE LA BIOMÉDECINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR DISEASE; CHILD; CHRONIC LUNG DISEASE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONVALESCENCE; CORONARY ARTERY DISEASE; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; FRAIL ELDERLY; FRANCE; GRANULOMATOSIS; HEART INFARCTION; HEMODIALYSIS; HUMAN; INFECTION; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MICROSCOPIC POLYANGIITIS; MORTALITY; NEOPLASM; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RELAPSE; SURVIVAL RATE; VERY ELDERLY; CASE CONTROL STUDY; CAUSE OF DEATH; COMPLICATION; EPIDEMIOLOGY; KAPLAN MEIER METHOD; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; REGISTER; RENAL REPLACEMENT THERAPY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; CASE-CONTROL STUDIES; CAUSE OF DEATH; CHILD; FEMALE; FRANCE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; REGISTRIES; RENAL DIALYSIS; RISK FACTORS; YOUNG ADULT;

EID: 84903794132     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcu043     Document Type: Article

References (31)

1. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013; 65:1-11.
2. Booth AD, Pusey CD, Jayne DR. Renal vasculitis-an update in 2004. Nephrol Dial Transplant 2004; 19:1964-8.
3. Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int 2003; 63:1164-77.
4. Booth AD, Almond MK, Burns A, Ellis P, Gaskin G, Neild GH, et al. Outcome of ANCA-associated renal vasculitis:a 5-year retrospective study. Am J Kidney Dis 2003; 41:776.
5. Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniené J, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003; 349:36-44.
6. Nachman PH, Hogan SL, Jennette JC, Falk RJ. Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996; 7:33-9.
7. de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R, Jayne DR, Gaskin G, Rasmussen N, et al. Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 2006; 17:2264-74.
8. Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD. ANCA-associated vasculitis with renal involvement:an outcome analysis. Nephrol Dial Transplant 2004; 19:1403-11.
9. Flossmann O, Berden A, de Groot K, Hagen C, Harper L, Heijl C, et al. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 2011; 70:488-94.
10. Slot MC, Tervaert JW, Franssen CF, Stegeman CA. Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int 2003; 63:670-7.
11. Jayne DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 2007; 18:2180-8.
12. Réseau Epidémiologie et Information en Néphrologie:Rapport REIN 2010. Nephrol Thér 2012; 1:1-218.
13. Canaud B, Tong L, Tentori F, Akiba T, Karaboyas A, Gillespie B, et al. Clinical practices and outcomes in elderly hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol 2011; 6:1651-62.
14. de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009; 302:1782-9.
15. Merino JL, Galeano C, Espejo B, Rivera M, Fernández-Lucas M, Caldés S, et al. A retrospective study on outcome of microscopic polyangiitis in chronic renal replacement therapy. Nephrol Dial Transplant 2011; 26:1360-6.
16. Weidanz F, Day CJ, Hewins P, Savage CO, Harper L. Recurrences and infections during continuous immunosuppressive therapy after beginning dialysis in ANCA-associated vasculitis. Am J Kidney Dis 2007; 50:36-46.
17. Allen A, Pusey C, Gaskin G. Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol 1998; 9:1258-63.
18. Couchoud C, Stengel B, Landais P, Aldigier JC, de Cornelissen F, Dabot C, et al. The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France. Nephrol Dial Transplant 2006; 21:411-8.
19. Couchoud C, Labeeuw M, Moranne O, Allot V, Esnault V, Frimat L, et al. Registry FREaINR: a clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease. Nephrol Dial Transplant 2009; 24:1553-61.
20. Lee SJ, Lindquist K, Segal MR, Covinsky KE. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 2006; 295:801-8.
21. Stratégie de prise en charge en cas de dénutrition protéinoénergétique chez la personne âgée-recommandation HAS avril 2007. http://www.has-sante.fr/portail/upload/docs/application/pdf/denutrition_personne_agee_2007_-_ argumentaire.pdf.
22. Roshanravan B, Robinson-Cohen C, Patel KV, Ayers E, Littman AJ, de Boer IH, et al. Association between physical performance and all-cause mortality in CKD. J Am Soc Nephrol 2013; 24:822-30.
23. Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, et al. Gait speed and survival in older adults. JAMA 2011; 305:50-8.
24. Lionaki S, Hogan SL, Jennette CE, Hu Y, Hamra JB, Jennette JC, et al. The clinical course of ANCA smallvessel vasculitis on chronic dialysis. Kidney Int 2009; 76:644-51.
25. Tang W, Bose B, McDonald SP, Hawley CM, Badve SV, Boudville N, et al. The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand. Clin J Am Soc Nephrol 2013; 8:773-80.
26. Walsh M, Casian A, Flossmann O, Westman K, Höglund P, Pusey C, et al. Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear. Kidney Int 2013; 84:397-402.
27. Nissenson AR, Port FK. Outcome of end-stage renal disease in patients with rare causes of renal failure. III. Systemic/vascular disorders. Q J Med 1990; 74:63-74.
28. Lukowsky LR, Kheifets L, Arah OA, Nissenson AR, Kalantar-Zadeh K. Patterns and predictors of early mortality in incident hemodialysis patients: new insights. Am J Nephrol 2012; 35:548-58.
29. Bradbury BD, Fissell RB, Albert JM, Anthony MS, Critchlow CW, Pisoni RL, et al. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol 2007; 2:89-99.
30. Collins AJ, Foley RN, Gilbertson DT, Chen SC. The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol 2009; 4(Suppl. 1):S5-11.
31. Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDIAL:a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998; 9:869-76.